Cargando…

Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice

Iron overload cardiomyopathy results from iron accumulation in the myocardium that is closely linked to iron-mediated myocardial fibrosis. Salvia miltiorrhiza (SM, also known as Danshen), a traditional Chinese medicinal herb, has been widely used for hundreds of years to treat cardiovascular disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ying, Wang, Hao, Cui, Lijing, Zhang, Yuanyuan, Liu, Yang, Chu, Xi, Liu, Zhenyi, Zhang, Jianping, Chu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388639/
https://www.ncbi.nlm.nih.gov/pubmed/25850001
http://dx.doi.org/10.1371/journal.pone.0124061
_version_ 1782365415386644480
author Zhang, Ying
Wang, Hao
Cui, Lijing
Zhang, Yuanyuan
Liu, Yang
Chu, Xi
Liu, Zhenyi
Zhang, Jianping
Chu, Li
author_facet Zhang, Ying
Wang, Hao
Cui, Lijing
Zhang, Yuanyuan
Liu, Yang
Chu, Xi
Liu, Zhenyi
Zhang, Jianping
Chu, Li
author_sort Zhang, Ying
collection PubMed
description Iron overload cardiomyopathy results from iron accumulation in the myocardium that is closely linked to iron-mediated myocardial fibrosis. Salvia miltiorrhiza (SM, also known as Danshen), a traditional Chinese medicinal herb, has been widely used for hundreds of years to treat cardiovascular diseases. Here, we investigated the effect and potential mechanism of SM on myocardial fibrosis induced by chronic iron overload (CIO) in mice. Kunming male mice (8 weeks old) were randomized to six groups of 10 animals each: control (CONT), CIO, low-dose SM (L-SM), high-dose SM (H-SM), verapamil (VRP) and deferoxamine (DFO) groups. Normal saline was injected in the CONT group. Mice in the other five groups were treated with iron dextran at 50 mg/kg per day intraperitoneally for 7 weeks, and those in the latter four groups also received corresponding daily treatments, including 3 g/kg or 6 g/kg of SM, 100 mg/kg of VRP, or 100 mg/kg of DFO. The iron deposition was estimated histologically using Prussian blue staining. Myocardial fibrosis was determined by Masson’s trichrome staining and hydroxyproline (Hyp) quantitative assay. Superoxide dismutase (SOD) activity, malondialdehyde (MDA) content and protein expression levels of type I collagen (COL I), type I collagen (COL III), transforming growth factor-β1 (TGF-β(1)) and matrix metalloproteinase-9 (MMP-9) were analyzed to investigate the mechanisms underlying the effects of SM against iron-overloaded fibrosis. Treatment of chronic iron-overloaded mice with SM dose-dependently reduced iron deposition levels, fibrotic area percentage, Hyp content, expression levels of COL I and COL III, as well as upregulated the expression of TGF- β(1) and MMP-9 proteins in the heart. Moreover, SM treatment decreased MDA content and increased SOD activity. In conclusion, SM exerted activities against cardiac fibrosis induced by CIO, which may be attributed to its inhibition of iron deposition, as well as collagen metabolism and oxidative stress.
format Online
Article
Text
id pubmed-4388639
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43886392015-04-21 Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice Zhang, Ying Wang, Hao Cui, Lijing Zhang, Yuanyuan Liu, Yang Chu, Xi Liu, Zhenyi Zhang, Jianping Chu, Li PLoS One Research Article Iron overload cardiomyopathy results from iron accumulation in the myocardium that is closely linked to iron-mediated myocardial fibrosis. Salvia miltiorrhiza (SM, also known as Danshen), a traditional Chinese medicinal herb, has been widely used for hundreds of years to treat cardiovascular diseases. Here, we investigated the effect and potential mechanism of SM on myocardial fibrosis induced by chronic iron overload (CIO) in mice. Kunming male mice (8 weeks old) were randomized to six groups of 10 animals each: control (CONT), CIO, low-dose SM (L-SM), high-dose SM (H-SM), verapamil (VRP) and deferoxamine (DFO) groups. Normal saline was injected in the CONT group. Mice in the other five groups were treated with iron dextran at 50 mg/kg per day intraperitoneally for 7 weeks, and those in the latter four groups also received corresponding daily treatments, including 3 g/kg or 6 g/kg of SM, 100 mg/kg of VRP, or 100 mg/kg of DFO. The iron deposition was estimated histologically using Prussian blue staining. Myocardial fibrosis was determined by Masson’s trichrome staining and hydroxyproline (Hyp) quantitative assay. Superoxide dismutase (SOD) activity, malondialdehyde (MDA) content and protein expression levels of type I collagen (COL I), type I collagen (COL III), transforming growth factor-β1 (TGF-β(1)) and matrix metalloproteinase-9 (MMP-9) were analyzed to investigate the mechanisms underlying the effects of SM against iron-overloaded fibrosis. Treatment of chronic iron-overloaded mice with SM dose-dependently reduced iron deposition levels, fibrotic area percentage, Hyp content, expression levels of COL I and COL III, as well as upregulated the expression of TGF- β(1) and MMP-9 proteins in the heart. Moreover, SM treatment decreased MDA content and increased SOD activity. In conclusion, SM exerted activities against cardiac fibrosis induced by CIO, which may be attributed to its inhibition of iron deposition, as well as collagen metabolism and oxidative stress. Public Library of Science 2015-04-07 /pmc/articles/PMC4388639/ /pubmed/25850001 http://dx.doi.org/10.1371/journal.pone.0124061 Text en © 2015 Zhang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Zhang, Ying
Wang, Hao
Cui, Lijing
Zhang, Yuanyuan
Liu, Yang
Chu, Xi
Liu, Zhenyi
Zhang, Jianping
Chu, Li
Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice
title Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice
title_full Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice
title_fullStr Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice
title_full_unstemmed Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice
title_short Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice
title_sort continuing treatment with salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388639/
https://www.ncbi.nlm.nih.gov/pubmed/25850001
http://dx.doi.org/10.1371/journal.pone.0124061
work_keys_str_mv AT zhangying continuingtreatmentwithsalviamiltiorrhizainjectionattenuatesmyocardialfibrosisinchronicironoverloadedmice
AT wanghao continuingtreatmentwithsalviamiltiorrhizainjectionattenuatesmyocardialfibrosisinchronicironoverloadedmice
AT cuilijing continuingtreatmentwithsalviamiltiorrhizainjectionattenuatesmyocardialfibrosisinchronicironoverloadedmice
AT zhangyuanyuan continuingtreatmentwithsalviamiltiorrhizainjectionattenuatesmyocardialfibrosisinchronicironoverloadedmice
AT liuyang continuingtreatmentwithsalviamiltiorrhizainjectionattenuatesmyocardialfibrosisinchronicironoverloadedmice
AT chuxi continuingtreatmentwithsalviamiltiorrhizainjectionattenuatesmyocardialfibrosisinchronicironoverloadedmice
AT liuzhenyi continuingtreatmentwithsalviamiltiorrhizainjectionattenuatesmyocardialfibrosisinchronicironoverloadedmice
AT zhangjianping continuingtreatmentwithsalviamiltiorrhizainjectionattenuatesmyocardialfibrosisinchronicironoverloadedmice
AT chuli continuingtreatmentwithsalviamiltiorrhizainjectionattenuatesmyocardialfibrosisinchronicironoverloadedmice